BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30104972)

  • 1.
    Turner E; Erwin M; Atigh M; Christians U; Saul JM; Yazdani SK
    Front Pharmacol; 2018; 9():808. PubMed ID: 30104972
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons.
    Goel E; Erwin M; Cawthon CV; Schaff C; Fedor N; Rayl T; Wilson O; Christians U; Register TC; Geary RL; Saul J; Yazdani SK
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32244375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons.
    Turner EA; Atigh MK; Erwin MM; Christians U; Yazdani SK
    Cardiovasc Eng Technol; 2018 Jun; 9(2):240-250. PubMed ID: 29497966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying the effect of drug-to-excipient ratio on drug release profile for drug coated balloons.
    Woolford S; Tran M; Yoda C; Oktem B; NguyenPho A; McDermott M; Wickramasekara S
    Int J Pharm; 2022 May; 620():121749. PubMed ID: 35427748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophilic Coating Microstructure Mediates Acute Drug Transfer in Drug-Coated Balloon Therapy.
    Shazly T; Eberth JF; Kostelnik CJ; Uline MJ; Chitalia VC; Spinale FG; Alshareef A; Kolachalama VB
    ACS Appl Bio Mater; 2024 May; 7(5):3041-3049. PubMed ID: 38661721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an automated micropipette coating method for drug-coated balloons.
    Fuglsby K; Anderson JA; Engebretson D; Lamichhane S
    J Biomed Mater Res B Appl Biomater; 2020 Jul; 108(5):2258-2275. PubMed ID: 31967398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of drug-coated balloon for the treatment of multiple peripheral artery segments.
    Anderson JA; Lamichhane S; Fuglsby K; Remund T; Pohlson K; Evans R; Engebretson D; Kelly P
    J Vasc Surg; 2020 May; 71(5):1750-1757.e7. PubMed ID: 31519510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Mechanism of Drug Transfer and Retention of Drug-Coated Balloons.
    Villar-Matamoros E; Stokes L; Lloret A; Todd M; Tillman BW; Yazdani SK
    J Cardiovasc Pharmacol Ther; 2022; 27():10742484221119559. PubMed ID: 35972237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlating coating characteristics with the performance of drug-coated balloons--a comparative in vitro investigation of own established hydrogel- and ionic liquid-based coating matrices.
    Kaule S; Minrath I; Stein F; Kragl U; Schmidt W; Schmitz KP; Sternberg K; Petersen S
    PLoS One; 2015; 10(3):e0116080. PubMed ID: 25734818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic coating morphology modulates acute drug transfer in drug-coated balloon therapy.
    Chang GH; Azar DA; Lyle C; Chitalia VC; Shazly T; Kolachalama VB
    Sci Rep; 2019 May; 9(1):6839. PubMed ID: 31048704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of balloon coating process for paclitaxel coated balloons via micro-pipetting method.
    Woolford SE; Tran M; NguyenPho A; McDermott MK; Oktem B; Wickramasekara S
    Int J Pharm; 2019 Jan; 554():312-321. PubMed ID: 30395954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro particulate and in vivo drug retention study of a novel polyethylene oxide formulation for drug-coated balloons.
    Anderson JA; Lamichhane S; Vierhout T; Sherman A; Engebretson D; Pohlson K; Remund T; Kelly P
    J Vasc Surg; 2018 May; 67(5):1537-1545.e7. PubMed ID: 28843789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel paclitaxel-coated angioplasty balloon catheter based on cetylpyridinium salicylate: preparation, characterization and simulated use in an in vitro vessel model.
    Petersen S; Kaule S; Stein F; Minrath I; Schmitz KP; Kragl U; Sternberg K
    Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4244-50. PubMed ID: 23910339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
    Krishnan P; Faries P; Niazi K; Jain A; Sachar R; Bachinsky WB; Cardenas J; Werner M; Brodmann M; Mustapha JA; Mena-Hurtado C; Jaff MR; Holden AH; Lyden SP
    Circulation; 2017 Sep; 136(12):1102-1113. PubMed ID: 28729250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balloon-based drug coating delivery to the artery wall is dictated by coating micro-morphology and angioplasty pressure gradients.
    Tzafriri AR; Muraj B; Garcia-Polite F; Salazar-Martín AG; Markham P; Zani B; Spognardi A; Albaghdadi M; Alston S; Edelman ER
    Biomaterials; 2020 Nov; 260():120337. PubMed ID: 32937269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic Evaluation of Two Paclitaxel-Coated Balloons with Different Drug Load in a Short-Term Porcine Study.
    Abadal JM; Vazquez E; Morales M; Toro A; Quintana M; Araujo M
    Cardiovasc Intervent Radiol; 2016 Aug; 39(8):1152-8. PubMed ID: 27094691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
    Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K
    JACC Cardiovasc Interv; 2014 Jan; 7(1):10-9. PubMed ID: 24456716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug loss from Paclitaxel-Coated Balloons During Preparation, Insertion and Inflation for Angioplasty: A Laboratory Investigation.
    Faenger B; Heinrich A; Hilger I; Teichgräber U
    Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1186-1197. PubMed ID: 35689119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of a paclitaxel-incorporated nanoparticle-coated balloon in rabbit and porcine models.
    Yamamoto E; Watanabe S; Bao B; Watanabe H; Nakatsuma K; Izuhara M; Ono K; Nakazawa G; Kimura T; Saito N
    Cardiovasc Revasc Med; 2018 Jun; 19(4):433-437. PubMed ID: 29174499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a magnesium stearate paclitaxel coated balloon catheter in the porcine coronary model.
    Bettink S; Löchel M; Peters D; Haider W; Speck U; Scheller B
    Int J Cardiol; 2021 May; 331():46-56. PubMed ID: 33418002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.